Literature DB >> 23471427

Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.

J J Jaller-Raad1, J J Jaller-Char, J A Lechuga-Ortiz, E Navarro-Lechuga, H Johansson, J A Kanis.   

Abstract

A FRAX model for Colombia was released June 30, 2010. This article describes the data used to develop the Colombian FRAX model and illustrates its features compared to other countries. Hip fracture cases aged 50 years or more who were referred to all hospitals serving the city of Barranquilla were identified prospectively over a 3-year period (2004-2006). Age- and sex-stratified hip fracture incidence rates were computed using the 2005 census. Present and future numbers of hip fracture cases in Colombia were calculated from the age- and sex-specific incidence and the national population demography. Mortality rates for 1999 were extracted from nationwide databases and used to estimate hip fracture probabilities. For other major fractures (clinical vertebral, forearm, and humerus), incidence rates were imputed, using Swedish ratios for hip to other major osteoporotic fracture, and used to construct the FRAX model. Incidence of hip fracture increased with age, more markedly in women than in men. Over all ages, the female to male ratio was 1.7. By extrapolation, there were estimated to be 7,902 new hip fracture cases (2,673 men, 5,229 women) in Colombia in 2010, which was predicted to increase to 22,720 cases (7,568 men, 15,152 women) in 2035. The 10-year probability of hip or major fracture was increased in patients with a clinical risk factor, lower BMI, female gender, a higher age, and a decreased BMD T score. The remaining lifetime probability of hip fracture at the age of 50 years was 2.5 and 4.7 % in men and women, respectively, which were lower than rates in a Mexican population (3.8 and 8.5 %, respectively) and comparable with estimates for Venezuela (2.4 and 7.5 %, respectively). The FRAX tool is the first country-specific fracture-prediction model available in Colombia. It is based on the original FRAX methodology, which has been externally validated in several independent cohorts. Despite some limitations, the strengths make the Colombian FRAX tool a good candidate for implementation into clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 23471427     DOI: 10.1007/s00223-013-9717-7

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

Review 1.  Geographic and ethnic disparities in osteoporotic fractures.

Authors:  Jane A Cauley; Didier Chalhoub; Ahmed M Kassem; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2014-04-22       Impact factor: 43.330

2.  Unmasking romosozumab: response to commentsby Uzoigwe et al.

Authors:  F Cosman; D B Crittenden; C Libanati
Journal:  Osteoporos Int       Date:  2017-02-17       Impact factor: 4.507

3.  Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.

Authors:  Bente Langdahl; Lorenz C Hofbauer; Serge Ferrari; Zhenxun Wang; Astrid Fahrleitner-Pammer; Evelien Gielen; Péter Lakatos; Edward Czerwinski; Esteban Jódar Gimeno; Jen Timoshanko; Mary Oates; Cesar Libanati
Journal:  Osteoporos Int       Date:  2022-09-29       Impact factor: 5.071

4.  Decreasing hip fracture rates among older adults in Chile, 2001-2019.

Authors:  Juan Cristóbal Ormeño; Rosario Martínez; Carolina Frías; Constanza Von Plessing; Iván Quevedo
Journal:  Arch Osteoporos       Date:  2022-01-29       Impact factor: 2.879

Review 5.  A brief history of FRAX.

Authors:  John A Kanis; Helena Johansson; Nicholas C Harvey; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2018-10-31       Impact factor: 2.617

Review 6.  Challenges and opportunities for quality densitometry in Latin America.

Authors:  Sergio Setsuo Maeda; Ramiro Da Silva LLibre; Henrique Pierotti Arantes; Guilherme Cardenaz de Souza; Francisco Fidencio Cons Molina; Diana Wiluzanski; Jorge Antonio Cedeño Taborda; Claudia Campusano Montaño; Tatiana Maida Vargas; Guillermo Luis Feldmann Lopez; Luis Vidal Neira; Gustavo Adolfo Molina Uribe; Daniel Salica; Ascanio Rafael Bencosme; Sonia Cerdas Perez; Carlos Ramón Rios Acosta; John J Carey; João Lindolfo Cunha Borges
Journal:  Arch Osteoporos       Date:  2021-02-02       Impact factor: 2.617

7.  Fragility fracture systems, Latin America perspective.

Authors:  Luis G Padilla Rojas; Roberto E López Cervantes; Leonardo López Almejo; Cesar A Pesciallo; Germán Garabano; Fernando Bidolegui; Vincenzo Giordano; William Dias Belangero; José Octavio Soares Hungria; Miguel Alvaro Triana Q; Amparo Gómez
Journal:  OTA Int       Date:  2022-06-09

8.  Frequency and Associated Factors of Bone Fractures in Russians: The Ural Eye and Medical Study.

Authors:  Mukharram M Bikbov; Rinat R Fayzrakhmanov; Gyulli M Kazakbaeva; Rinat M Zainullin; Venera F Salavatova; Timur R Gilmanshin; Inga I Arslangareeva; Nikolai A Nikitin; Songhomitra Panda-Jonas; Svetlana R Mukhamadieva; Dilya F Yakupova; Renat I Khikmatullin; Said K Aminev; Ildar F Nuriev; Artur F Zaynetdinov; Yulia V Uzianbaeva; Jost B Jonas
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.